. 2018 Jul 25;62:10.29219/fnr.v62.1398. doi: 10.29219/fnr.v62.1398

Table 2.

Effects of pretreatment with FPLR on the levels of serum ALT, AST, ALP, TG, TC, and TBIL in CCl₄-treated mice ( $\bar{X}$ ± SD, n = 10)

Groups	ALT(U/L)	AST (U/L)	ALP (U/L)	TG (mmol/L)	TC (mmol/L)	TBIL (μmol/L)
Normal control	117.20 ± 23.59^d	361.50 ± 28.02^e	85.75 ± 4.65^b	1.18 ± 0.06^d	1.16 ± 0.11^e	0.47 ± 0.08^c
CCl₄ -treated	1120.56 ± 189.36^a	1594.89 ± 112.28^a	110.67 ± 13.42^a	1.42 ± 0.09^a	2.58 ± 0.24^a	6.48 ± 1.01^a
Bifendate (100 mg/kg bw) + CCl₄	610.70 ± 92.67^c	698.50 ± 100.5^d	92.9 ± 10.9^ab	1.22 ± 0.08^cd	1.61 ± 0.12^d	3.31 ± 0.57^b
FPLR (50 mg/kg bw) + CCl₄	987.32 ± 101.31^ab	1230.55 ± 163.54^bc	103.38 ± 9.38^a	1.31 ± 0.05^b	1.92 ± 0.15^bc	5.76 ± 1.12^a
FPLR (100 mg/kg bw) + CCl₄	839.59 ± 118.52^b	1026.18 ± 97.17^cd	84.89 ± 8.25^b	1.28 ± 0.05^bc	1.78 ± 0.21^cd	5.31 ± 0.65^a
FPLR (200 mg/kg bw) + CCl₄	1011.75 ± 103.92^ab	1335.78 ± 98.66^b	105.00 ± 3.61^a	1.30 ± 0.08^bc	2.12 ± 0.10^b	5.53 ± 0.89^a

Data are shown as mean values ± SD for the 10 mice in each group. Values within a column with different letters indicate significant difference among different groups at p < 0.05.